Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of Long-Acting Risperidone in the Maintenance Treatment of First-Episode Schizophrenia

NCT00220714 is registered in ClinicalTrials.gov with State University of New York - Downstate Medical Center as lead sponsor.

NCT NCT00220714
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00220714 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of Long-Acting Risperidone in the Maintenance Treatment of First-Episode Schizophrenia
Lead sponsor
State University of New York - Downstate Medical Center
Phase
Phase 4
Overall status
Unknown status
Start date
November 30, 2004
Completion date
December 31, 2007
Enrollment
80
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia